scholarly journals Implantable Defibrillator Therapy in Cardiac Arrest Survivors With a Reversible Cause

2018 ◽  
Vol 11 (3) ◽  
Author(s):  
Adetola Ladejobi ◽  
Deepak K. Pasupula ◽  
Shubash Adhikari ◽  
Awais Javed ◽  
Asad F. Durrani ◽  
...  
Keyword(s):  
Cardiac Arrest ◽  
Implantable Defibrillator

Surveillance after cardiac arrest in patients with Brugada syndrome without an implantable defibrillator: An alarm effect of the previous syncope

2016 ◽  
Vol 218 ◽  
pp. 69-74 ◽  
Author(s):  
David Calvo ◽  
Juan Pablo Flórez ◽  
Irene Valverde ◽  
José Rubín ◽  
Diego Pérez ◽  
...  
Keyword(s):  
Cardiac Arrest ◽  
Brugada Syndrome ◽  
Implantable Defibrillator

scholarly journals Clinical dilemma of management: Cardiac arrest after microsclerotherapy for lower limb telangiectasia with liquid 0.3% aethoxysklerol or idiopathic cardiac arrest?

2021 ◽  
Vol 9 ◽  
pp. 2050313X2110008
Author(s):  
Mark S Whiteley ◽  
Laura K Taylor ◽  
Julie C King ◽  
Brittany E Hughes
Keyword(s):  
Myocardial Infarction ◽  
Cardiac Arrest ◽  
Lower Limb ◽  
Implantable Defibrillator ◽  
Endothelin 1 ◽  
Clinical Dilemma ◽  
Hospital Protocol

A 48-year-old woman attended to discuss a dilemma. She had suffered a cardiac arrest immediately following microsclerotherapy of leg telangiectasia with 0.3% aethoxysklerol. She had successful defibrillation and been transferred to hospital. In hospital, despite normal cardiac tests, she was diagnosed as having idiopathic cardiac arrest. The exposure to aethoxysklerol was discounted by her cardiologists as a cause of her arrest. Following the hospital protocol, she was strongly advised to have an implantable defibrillator. Cardiac arrest and myocardial infarction are documented after aethoxysklerol injection with proposed mechanisms being anaphylaxis, direct cardiotoxicity or endothelin-1 release. Before consenting to an implantable defibrillator, which may have its own complications in the long term, doctors and the patient need to be certain that this arrest was not due to a reaction to aethoxysklerol.

scholarly journals Paro cardiorrespiratorio intraoperatorio en un paciente con síndrome de Brugada

2020 ◽  
Vol 49 (4) ◽  
pp. 571-575
Author(s):  
Ignacia López L. ◽  
Claudio Pacheco C. ◽  
Francisco Cruzat R.
Keyword(s):  
Nitrous Oxide ◽  
Cardiac Arrest ◽  
Ventricular Fibrillation ◽  
General Anesthesia ◽  
Female Patient ◽  
Surgical Procedure ◽  
Implantable Defibrillator ◽  
St Segment ◽  
History Of ◽  
A Minor

A 61-year-old female patient with history of hipertension is scheduled to undergo a minor ginecological procedure (endoscopic endometrial polipus resection) with general anesthesia. She received standard monitorization, induction with midazolam, propofol and fentanyl. Ventilated with laringeal mask. Anesthesia was maintained with sevoflurane, nitrous oxide and oxygen. During surgical procedure, the patient received atropine and ephedrine associated with two episodes of bradycardia without hemodinamic disturbances. The surgery ended without problems. During the weaking up process she presented characteristical waves of ventricular fibrillation, recuperating sinusal rhythm secondary to defibrillation with 360 J. There was no clear cause for cardiac arrest at that moment so patient was translated to the ICU for observation, monitoring and study. Postoperative EKG presented an ascending ST segment in V to V derivations without hemodynamic alterations associated. The possible diagnosis of Brugada’s Syndrome was proposed. The patient received an implantable defibrillator. The mechanisms and anesthetic implications are discussed and reviewed.

Sign in / Sign up

Export Citation Format

Share Document